Royal Bank of Canada’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$797K Buy
7,641
+840
+12% +$87.6K ﹤0.01% 3777
2025
Q1
$794K Sell
6,801
-14,114
-67% -$1.65M ﹤0.01% 3320
2024
Q4
$1.77M Buy
20,915
+5,267
+34% +$446K ﹤0.01% 2730
2024
Q3
$1.41M Sell
15,648
-496
-3% -$44.5K ﹤0.01% 2902
2024
Q2
$1.3M Buy
16,144
+131
+0.8% +$10.5K ﹤0.01% 2921
2024
Q1
$1.28M Sell
16,013
-10,224
-39% -$816K ﹤0.01% 2899
2023
Q4
$2.09M Buy
26,237
+6,384
+32% +$508K ﹤0.01% 2617
2023
Q3
$1.39M Buy
19,853
+12,520
+171% +$875K ﹤0.01% 2751
2023
Q2
$527K Buy
7,333
+1,909
+35% +$137K ﹤0.01% 3518
2023
Q1
$335K Sell
5,424
-2,949
-35% -$182K ﹤0.01% 3841
2022
Q4
$646K Buy
8,373
+3,877
+86% +$299K ﹤0.01% 3442
2022
Q3
$201K Buy
4,496
+712
+19% +$31.8K ﹤0.01% 4294
2022
Q2
$144K Sell
3,784
-2,078
-35% -$79.1K ﹤0.01% 4607
2022
Q1
$242K Sell
5,862
-3,804
-39% -$157K ﹤0.01% 4448
2021
Q4
$365K Buy
9,666
+2,920
+43% +$110K ﹤0.01% 4255
2021
Q3
$223K Buy
6,746
+3,208
+91% +$106K ﹤0.01% 4571
2021
Q2
$238K Buy
3,538
+708
+25% +$47.6K ﹤0.01% 4464
2021
Q1
$160K Buy
2,830
+2,662
+1,585% +$151K ﹤0.01% 4639
2020
Q4
$14K Buy
168
+136
+425% +$11.3K ﹤0.01% 5664
2020
Q3
$2K Sell
32
-176
-85% -$11K ﹤0.01% 5799
2020
Q2
$17K Buy
208
+102
+96% +$8.34K ﹤0.01% 5170
2020
Q1
$6K Buy
+106
New +$6K ﹤0.01% 5465
2018
Q4
Sell
-39
Closed 5796
2018
Q3
$0 Buy
+39
New ﹤0.01% 6088
2018
Q1
Sell
-19
Closed 5700
2017
Q4
$0 Buy
19
+16
+533% ﹤0.01% 5764
2017
Q3
$0 Buy
+3
New ﹤0.01% 5926
2017
Q2
Sell
-696
Closed -$3K 5788
2017
Q1
$3K Sell
696
-63
-8% -$272 ﹤0.01% 5647
2016
Q4
$5K Buy
+759
New +$5K ﹤0.01% 5522